Long Term Use of Valganciclovir for Prophylaxis of CMV Disease in Kidney and Pancreas Transplant Patients
This study has been completed.
Sponsor:
University of Massachusetts, Worcester
Collaborators:
Beth Israel Deaconess Medical Center
Lahey Clinic
Rhode Island Hospital
Information provided by:
University of Massachusetts, Worcester
ClinicalTrials.gov Identifier:
NCT00225394
First received: September 21, 2005
Last updated: NA
Last verified: August 2005
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | July 2006 |
| Estimated Primary Completion Date: | No date given |